Orthokeratology Lens Global Market Report 2024

The orthokeratology lens market size has grown strongly in recent years. It will grow from $2.36 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed during the historical period can be credited to factors such as the focus on myopia management, advancements in lens materials, a growing demand for non-surgical vision correction methods, the increased convenience associated with lifestyle preferences, and the emphasis on pediatric vision correction.

The orthokeratology lens market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period can be linked to several factors, including the increasing prevalence of myopia, a trend towards customization and personalization in vision correction, rising healthcare awareness, the global expansion of orthokeratology services, and an increase in disposable income. Major trends expected in the forecast period encompass technological innovations, integration with digital health platforms, collaborations with eye care professionals, advancements in material technologies, and the development of smart and innovative lens designs.

The rising incidence of eye-related disorders is anticipated to drive the growth of the orthokeratology lens market in the coming years. Eye disorders, also known as ophthalmic conditions, encompass a wide range of medical issues and abnormalities affecting the eyes and their associated structures. Orthokeratology (Ortho-K) lenses are primarily utilized to correct refractive errors, such as myopia (nearsightedness), and to provide temporary vision correction without the need for eyeglasses or daytime contact lenses. For instance, in December 2022, the Centers for Disease Control and Prevention reported that approximately 20.5 million Americans over the age of 40, constituting 17.2% of the population, have at least one cataract. It is estimated that by 2028, 30 million individuals will have cataracts. Consequently, the rising incidence of eye-related disorders is propelling the growth of the orthokeratology lens market.

The rising geriatric population is also expected to contribute to the growth of the orthokeratology lens market in the future. The geriatric population, referring to individuals aged 65 and older, stands to benefit from orthokeratology lenses, providing non-surgical vision correction and improving near and distant vision without the reliance on daytime glasses or contact lenses. According to the World Health Organization's October 2022 report, it is projected that by 2030, 1 in 6 individuals globally will be 60 years of age or older, and the global elderly population is anticipated to reach 2.1 billion by 2050. Therefore, the rising geriatric population is a key factor driving the growth of the orthokeratology lens market.

The high cost associated with treatment poses a significant challenge that hampers the growth of the orthokeratology lens market. Orthokeratology treatment, commonly known as ortho-k, is a non-surgical therapeutic procedure that utilizes specially designed rigid contact lenses to temporarily reshape the cornea of the eye. The elevated cost of orthokeratology treatment acts as a constraint on the growth of the orthokeratology lens market, as it renders the treatment less accessible and affordable for potential patients. This limitation narrows the market's potential customer base, impeding its overall expansion. For example, NVISION Eye Centers, a US-based eye care services company, reports that orthokeratology typically costs between $600 to $1,200 per eye, with more complex cases potentially reaching $2,000 or higher per eye. These costs do not cover additional expenses for replacement lenses, follow-up appointments, or lens solutions. Therefore, the high treatment cost is a significant hindrance to the growth of the orthokeratology lens market.

Major companies operating in the orthokeratology lens market are focusing on developing innovative products such as Menicon Z Night. Menicon Z Night is a specific type of orthokeratology lens designed to reshape the cornea and address refractive issues such as myopia, hyperopia, and astigmatism. For instance, in May 2023, Menicon Co. Ltd., a Japan-based eyewear company, introduced Menicon Z Night, an orthokeratology lens for short-term corneal reshaping and vision improvement. The lens, worn at night to treat myopia and/or astigmatism, demonstrates effective myopia reduction and provides stable vision after a week of use. It is well-tolerated, and its fitting utilizes computer software to ensure a high first-fit success rate.

In June 2022, CooperVision Inc., a US-based contact lens manufacturing company, acquired EnsEyes ApS for an undisclosed amount. This strategic move allows CooperVision Specialty EyeCare to enhance its portfolio by offering a range of industry-leading soft and custom rigid gas permeable lens designs, including orthokeratology and scleral lenses. The acquisition of EnsEyes ApS, a Denmark-based provider of orthokeratology and scleral contact lenses, reinforces CooperVision's presence in segments such as myopia management, irregular cornea, and presbyopia.

Major companies operating in the orthokeratology lens market report are Essilor International, Johnson & Johnson Vision Care Inc., Alcon Inc., Bausch & Lomb Inc., CooperVision Inc., Orion Vision Group, Lucid Korea Co. Ltd., St. Shine Optical Co. Ltd., Autek China Inc., ABB Optical Group, Brighten Optix Co., E&E Optics Inc., Visioneering Technologies Inc., Alpha Corporation, Paragon Vision Sciences, Euclid Systems Corp., Contamac Ltd., SynergEyes Inc., Mark'ennovy Personalized Care Ltd., Art Optical Contact Lens Inc., GP Specialists Lens Inc., MiracLens LLC, TruForm Optics Inc., Corneal Lens Corporation, SwissLens S.A., Gelflex, Valley Contax Inc., Capricornia Contact Lens Pty Ltd., EyeKrafters Medical Optics, Metro Optics.

North America was the largest region in the orthokeratology lens market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthokeratology lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthokeratology lens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Orthokeratology lenses are specialized rigid gas-permeable contact lenses created with the purpose of temporarily reshaping the cornea, which is the clear, dome-shaped front surface of the eye. They are primarily utilized for the correction and management of nearsightedness (myopia), aiming to eliminate the necessity for glasses or contact lenses during the day.

The primary categories of orthokeratology lenses include daytime ortho-k lenses and overnight ortho-k lenses. Daytime orthokeratology (Ortho-K) lenses, also referred to as daytime ortho-K lenses or corneal refractive therapy (CRT), constitute a specific type of contact lens designed to address vision correction needs during waking hours without relying on glasses or traditional daytime contact lenses. These lenses are crafted from various materials such as silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. They are employed in the treatment of various visual conditions, including myopia, presbyopia, hypermetropia, and astigmatism. The distribution of these lenses is typically facilitated through hospitals, optometry clinics, ophthalmology clinics, and other relevant channels.

The orthokeratology lens market research report is one of a series of new reports that provides orthokeratology lens market statistics, including orthokeratology lens industry global market size, regional shares, competitors with an orthokeratology lens market share, detailed orthokeratology lens market segments, market trends and opportunities, and any further data you may need to thrive in the orthokeratology lens industry. This orthokeratology lens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The orthokeratology lens market consists of revenues earned by entities by provide services such as myopia control, overnight correction, and customized fitting. The market value includes the value of related goods sold by the service provider or included within the service offering. The Orthokeratology lens market also includes sales of ortho-k lens Designs, ortho-k lens materials, myopia control ortho-k lenses, custom-fitted ortho-k lenses, and ortho-k accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.